220
article
A Prescription for Brain Disease Research
The population is aging, and so are its brains. Neurodegenerative diseases are impacting more people
—those who are diagnosed and their loved ones—bringing with them higher costs for all.
+ Read More
article
Why Taking Chances in Developing Rare Disease Medicines Is Worth the Risk
Of the 7,000 known rare diseases in the world, only 5 percent have treatments. This means that a lar
ge majority of those who live with rare diseases are left without meaningful options—and some, without hope.
+ Read More
article
Aligning Science Across Parkinson’s: A Collaborative Model for Accelerating Biomedical Research
Around the globe, biomedical research has advanced dramatically since the end of the Second World Wa
r when government support for basic science in the US began.
+ Read More
article
Balancing the Innovation Premium with the Quality of Health Care in the US
The US health-care system is unique. It can offer the best medical care, including the most innovati
ve treatment options. At the same time, it can deny access to basic care or may drive patients into personal bankruptcy.
+ Read More
article
FinTech in Focus—October 14, 2019
In this issue:
Industry Headlines »
Global Developments »
article
FinTech in Focus–October 7, 2019
In this issue:
Racking up sky miles like Edward Norton »
Industry Headlines »
Global Developments
»
+ Read More
video
Closing Plenary | The Global Investment Outlook
video